Pharmacokinetics of cefixime in the young and elderly
- PMID: 3410802
- DOI: 10.1093/jac/21.6.787
Pharmacokinetics of cefixime in the young and elderly
Abstract
The pharmacokinetics of cefixime were compared in 12 young and 12 elderly subjects receiving 400 mg once-a-day for five days. Mean peak serum concentrations (Cmax) on days one and five in the elderly (4.90 and 5.68 mg/l) were comparable (P greater than 0.05) to those in the young subjects (3.88 and 4.74 mg/l). Serum area under the curve (AUC) values on days one and five in the elderly (41.0 and 49.5 mg.h/l) were higher (P less than 0.05) than those in young subjects (28.6 and 34.9 mg.h/l). In addition, the elimination half-life, mean residence time, average concentration, minimal concentration and renal clearance (Clr) values were significantly higher (P less than 0.05) in the elderly. A significant linear correlation (P less than 0.05) was found between the Clr of cefixime (total and unbound) and creatinine clearance. The urinary recovery (Ae0----24) and protein binding of cefixime on days one and five was similar in the elderly and young. Overall, there is no need for any dosage adjustment of the drug in the elderly.
Similar articles
-
Relationship between renal function and disposition of oral cefixime.Eur J Clin Pharmacol. 1991;41(6):579-83. doi: 10.1007/BF00314988. Eur J Clin Pharmacol. 1991. PMID: 1815970
-
[Pharmacokinetic properties of cefixime].Presse Med. 1989 Oct 11;18(32):1578-82. Presse Med. 1989. PMID: 2530536 French.
-
The pharmacokinetics of cefixime in the fasted and fed state.Eur J Clin Pharmacol. 1988;34(5):525-8. doi: 10.1007/BF01046715. Eur J Clin Pharmacol. 1988. PMID: 3203716
-
[Pulmonary diffusion of cefixime in man].Presse Med. 1989 Oct 11;18(32):1589-92. Presse Med. 1989. PMID: 2530539 Review. French.
-
Pharmacokinetics of cefodizime: a review of the data on file.J Antimicrob Chemother. 1990 Nov;26 Suppl C:95-101. doi: 10.1093/jac/26.suppl_c.95. J Antimicrob Chemother. 1990. PMID: 2074258 Review.
Cited by
-
Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.Drugs. 1989 Oct;38(4):524-50. doi: 10.2165/00003495-198938040-00004. Drugs. 1989. PMID: 2684593 Review.
-
Clinical pharmacokinetics of newer cephalosporins.Clin Pharmacokinet. 1995 May;28(5):361-84. doi: 10.2165/00003088-199528050-00003. Clin Pharmacokinet. 1995. PMID: 7614776 Review.
-
Relationship between renal function and disposition of oral cefixime.Eur J Clin Pharmacol. 1991;41(6):579-83. doi: 10.1007/BF00314988. Eur J Clin Pharmacol. 1991. PMID: 1815970
-
Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.Antimicrob Agents Chemother. 1992 Jan;36(1):144-9. doi: 10.1128/AAC.36.1.144. Antimicrob Agents Chemother. 1992. PMID: 1590680 Free PMC article. Clinical Trial.
-
Considerations in dosage selection for third generation cephalosporins.Clin Pharmacokinet. 1992 Feb;22(2):132-43. doi: 10.2165/00003088-199222020-00004. Clin Pharmacokinet. 1992. PMID: 1551290 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources